Patty E. Vonk
YOU?
Author Swipe
View article: “Super‐Responders” to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal Polyps
“Super‐Responders” to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal Polyps Open
Background Dupilumab is effective in treating patients with type‐2 dominant chronic rhinosinusitis with nasal polyps (T2‐CRSwNP). Dosing starts at an interval of 1×/2 weeks (Q2W) with possible tapering upon disease control. Prolonging the …
View article: Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions
Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions Open
NCT02806895, EudraCT 2015-003930-28: A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects With Excessive Sleepiness Due to Obstructive Sleep Apne…
View article: Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea Open
Objective To evaluate the impact of solriamfetol, a dopamine and norepinephrine reuptake inhibitor, on on‐the‐road driving in participants with excessive daytime sleepiness (EDS) associated with obstructive sleep apnoea (OSA). Methods Elig…
View article: 0673 Effects Of Solriamfetol On Driving Performance In Participants With Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea
0673 Effects Of Solriamfetol On Driving Performance In Participants With Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Open
Introduction Excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea (OSA) is associated with an increased risk of driving accidents. Solriamfetol, a dopamine/norepinephrine reuptake inhibitor, is approved in the US (Su…
View article: The role of drug-induced sleep endoscopy and position-dependency in the diagnostic work-up of obstructive sleep apnea
The role of drug-induced sleep endoscopy and position-dependency in the diagnostic work-up of obstructive sleep apnea Open
We evaluated different passive maneuvers during drug-induced sleep endoscopy (DISE) in obstructive sleep apnea (OSA) patients. Jaw thrust is performed to mimic the effect of a mandibular advancement device (MAD); lateral head rotation to s…
View article: European position paper on drug‐induced sleep endoscopy: 2017 Update
European position paper on drug‐induced sleep endoscopy: 2017 Update Open
Background The first edition of the European position paper ( EPP ) on drug‐induced sleep endoscopy ( DISE ) was published in 2014 with the aim to standardise the procedure, to provide an in‐depth insight into the main aspects of this tech…